These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3741916)

  • 1. The dexamethasone suppression test in panic disorder and major depressive episodes.
    Faludi G; Kaskó M; Perényi A; Arató M; Frecska E
    Biol Psychiatry; 1986 Sep; 21(11):1008-14. PubMed ID: 3741916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamic-pituitary-adrenal system in panic disorder.
    Goldstein S; Halbreich U; Asnis G; Endicott J; Alvir J
    Am J Psychiatry; 1987 Oct; 144(10):1320-3. PubMed ID: 3661766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone suppression test in patients with panic attacks.
    Bridges M; Yeragani VK; Rainey JM; Pohl R
    Biol Psychiatry; 1986 Jul; 21(8-9):853-5. PubMed ID: 3730467
    [No Abstract]   [Full Text] [Related]  

  • 4. The dexamethasone suppression test in panic disorder: comparison with normal controls.
    Roy-Byrne PP; Bierer LM; Uhde TW
    Biol Psychiatry; 1985 Nov; 20(11):1237-40. PubMed ID: 4052520
    [No Abstract]   [Full Text] [Related]  

  • 5. Serial dexamethasone suppression tests in simultaneous panic and depressive disorders.
    Grunhaus L; Flegel P; Haskett RF; Greden JF
    Biol Psychiatry; 1987 Mar; 22(3):332-8. PubMed ID: 3814682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone suppression test in agoraphobia.
    Peterson GA; Ballenger JC; Cox DP; Hucek A; Lydiard RB; Laraia MT; Trockman C
    J Clin Psychopharmacol; 1985 Apr; 5(2):100-2. PubMed ID: 3988966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of HPA axis disturbance in panic disorder.
    Coryell W; Noyes R; Schlechte J
    Biol Psychiatry; 1989 Apr; 25(8):989-1002. PubMed ID: 2720018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
    Holsboer F; von Bardeleben U; Wiedemann K; Müller OA; Stalla GK
    Biol Psychiatry; 1987 Feb; 22(2):228-34. PubMed ID: 3028512
    [No Abstract]   [Full Text] [Related]  

  • 10. Association performance and the DST.
    Demeter E; Rihmer Z; Arato M; Frecska E
    Psychiatry Res; 1986 Jul; 18(3):289-90. PubMed ID: 3749388
    [No Abstract]   [Full Text] [Related]  

  • 11. The metyrapone test in affective disorders and schizophrenia.
    Fava GA; Carson SW; Perini GI; Morphy MA; Molnar G; Jusko WJ
    J Affect Disord; 1984 Jun; 6(3-4):241-7. PubMed ID: 6235255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
    Arana GW; Wilens TE; Baldessarini RJ
    Psychoneuroendocrinology; 1985; 10(1):49-60. PubMed ID: 4001277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reported weight loss and dexamethasone nonsuppression in depressed patients. A negative study.
    Gwirtsman HE; Roy-Byrne P; Gitlin MJ; Halaris A; Ahles S
    J Affect Disord; 1985 Sep; 9(2):193-6. PubMed ID: 2932495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

  • 15. Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology.
    Gerken A; Maier W; Holsboer F
    Psychoneuroendocrinology; 1985; 10(3):261-71. PubMed ID: 4059474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF; Prudic J; Rothpearl A; Nurnberg HG
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
    Magni G; Schifano F; De Leo D; De Dominicis MG; Garbin A; Zangaglia O
    Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dexamethasone suppression test and unipolar-bipolar classification of depression].
    Ayuso Gutiérrez JL; García-Camba E; Cabranes JA; Almoguera MI
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1985; 13(1):1-4. PubMed ID: 4025025
    [No Abstract]   [Full Text] [Related]  

  • 19. The dex/CRH test--is it better than the DST?
    Watson S; Gallagher P; Smith MS; Ferrier IN; Young AH
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
    Roy A; Jimerson DC; Pickar D
    Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.